Thiazides and calcium stones: Overrated or underused?

John J. Knoedler, Amy E. Krambeck

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The lifetime incidence of urolithiasis is approximately 10-15∈% in the USA, with calcium-containing stones the most common offender. Among recurrent stone formers, thiazide-type diuretics have traditionally represented first-line therapy for prevention of recurrent calcium stones. However, with improved understanding of the benefits of lifestyle modification and alternative therapies for stone prevention, the utility of thiazides as first-line agents has recently come into question. This chapter will explore the rational for thiazide usage in the prevention of recurrent calcium stone disease, evaluate the evidence in favor of and against thiazides as first-line therapy, and finally examine the cost-effective use of thiazides and their comparative effectiveness to alternative forms of treatment.

Original languageEnglish (US)
Title of host publicationPractical Controversies in Medical Management of Stone Disease
PublisherSpringer New York
Pages131-141
Number of pages11
Volume9781461495758
ISBN (Electronic)9781461495758
ISBN (Print)1461495741, 9781461495741
DOIs
StatePublished - Nov 1 2014

    Fingerprint

Keywords

  • Hypercalciuria
  • Nephrolithiasis
  • Stones kidney
  • Thiazide diuretic

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Knoedler, J. J., & Krambeck, A. E. (2014). Thiazides and calcium stones: Overrated or underused? In Practical Controversies in Medical Management of Stone Disease (Vol. 9781461495758, pp. 131-141). Springer New York. https://doi.org/10.1007/978-1-4614-9575-8_10